Alnylam Pharmaceuticals(ALNY) - 2025 Q4 - Earnings Call Transcript

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsChristine Lindenboom - Chief Corporate Communications OfficerJeff Poulton - CFOPushkal Garg - Chief Research and Development OfficerTolga Tanguler - Chief Commercial OfficerYvonne Greenstreet - CEOConference Call ParticipantsAlexander Canani - AnalystCory Kasimov - AnalystEllie Merle - AnalystJames Sheehan - AnalystKostas Theodoslou - AnalystLuca Issi - AnalystMaury Raycroft - AnalystMike Ulz - An ...